001     862752
005     20210130001608.0
024 7 _ |a 10.1016/j.chemphyslip.2019.02.009
|2 doi
024 7 _ |a 0009-3084
|2 ISSN
024 7 _ |a 1873-2941
|2 ISSN
024 7 _ |a 2128/22181
|2 Handle
024 7 _ |a pmid:30826264
|2 pmid
024 7 _ |a WOS:000464480000008
|2 WOS
024 7 _ |a altmetric:57105515
|2 altmetric
037 _ _ |a FZJ-2019-02994
082 _ _ |a 530
100 1 _ |a Falke, Marcel
|0 P:(DE-HGF)0
|b 0
245 _ _ |a α-Synuclein-derived lipoparticles in the study of α-Synuclein amyloid fibril formation
260 _ _ |a Amsterdam [u.a.]
|c 2019
|b Elsevier Science
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1557840054_24070
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Aggregation of the protein α-Synuclein (αSyn) is of great interest due to its involvement in the pathology of Parkinson’s disease. However, under in vitro conditions αSyn is very soluble and kinetically stable for extended time periods. As a result, most αSyn aggregation assays rely on conditions that artificially induce or enhance aggregation, often by introducing rather non-native conditions. It has been shown that αSyn interacts with membranes and conditions have been identified in which membranes can promote as well as inhibit αSyn aggregation. It has also been shown that αSyn has the intrinsic capability to assemble lipid-protein-particles, in a similar way as apolipoproteins can form lipid-bilayer nanodiscs. Here we show that these αSyn-lipid particles (αSyn-LiPs) can also effectively induce, accelerate or inhibit αSyn aggregation, depending on the applied conditions. αSyn-LiPs therefore provide a general platform and additional tool, complementary to other setups, to study various aspects of αSyn amyloid fibril formation.
536 _ _ |a 553 - Physical Basis of Diseases (POF3-553)
|0 G:(DE-HGF)POF3-553
|c POF3-553
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a Victor, Julian
|0 0000-0002-2720-0657
|b 1
700 1 _ |a Wördehoff, Michael M.
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Peduzzo, Alessia
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Zhang, Tao
|0 P:(DE-Juel1)177882
|b 4
700 1 _ |a Schröder, Gunnar F.
|0 P:(DE-Juel1)132018
|b 5
700 1 _ |a Buell, Alexander K.
|0 0000-0003-1161-3622
|b 6
700 1 _ |a Hoyer, Wolfgang
|0 P:(DE-Juel1)166306
|b 7
700 1 _ |a Etzkorn, Manuel
|0 P:(DE-Juel1)156341
|b 8
|e Corresponding author
773 _ _ |a 10.1016/j.chemphyslip.2019.02.009
|g Vol. 220, p. 57 - 65
|0 PERI:(DE-600)1496839-3
|p 57 - 65
|t Chemistry and physics of lipids
|v 220
|y 2019
|x 0009-3084
856 4 _ |y OpenAccess
|u https://juser.fz-juelich.de/record/862752/files/%CE%B1-Synuclein-derived%20lipoparticles%20in%20the%20study%20of%20%CE%B1-Synuclein%20amyloid%20fibril%20formation.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://juser.fz-juelich.de/record/862752/files/%CE%B1-Synuclein-derived%20lipoparticles%20in%20the%20study%20of%20%CE%B1-Synuclein%20amyloid%20fibril%20formation.pdf?subformat=pdfa
909 C O |o oai:juser.fz-juelich.de:862752
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 4
|6 P:(DE-Juel1)177882
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 5
|6 P:(DE-Juel1)132018
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 7
|6 P:(DE-Juel1)166306
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 8
|6 P:(DE-Juel1)156341
913 1 _ |a DE-HGF
|b Key Technologies
|l BioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences
|1 G:(DE-HGF)POF3-550
|0 G:(DE-HGF)POF3-553
|2 G:(DE-HGF)POF3-500
|v Physical Basis of Diseases
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2019
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CHEM PHYS LIPIDS : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)ICS-6-20110106
|k ICS-6
|l Strukturbiochemie
|x 0
980 1 _ |a FullTexts
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)ICS-6-20110106
981 _ _ |a I:(DE-Juel1)IBI-7-20200312


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21